Chang L,Zhao J,Xu J,et al. Effects of taurine and homocysteine on calcium homeostasis and hydrogen peroxide and super-oxide anions in rat myocardial mitochondria[J]. Clin Exp Pharmacol Physiol,2004,31:237-243.
[2]
Wu LL. Review of risk factors for cardiovascular disease[J]. Ann Clin Lab Sei,1999,29(2):127-133.
[3]
Dinckal MH, AksoyN, Aksoy M, et al. Effect of Homocysteine lowering therapy on vascular endothelial function and exercise performance in coronary patients with hyperhomocysteinemia[J]. Acta Cardiol,2003, 58(5): 389-396.
[4]
HirschS, Ronco AM, Vasquez M, et al. Hyperhomocysteinemia in healthy young men and eldly men with normal serum folate concertration is not associated with poor vascular reactivity or stress[J].Nurtrion, 2004,137(7):1832-1835.
[5]
Stanger O, Fowler B, Herrmann W. Folate therapy and instant restenosis[J].N Engl J Med,2004,350(26):1259-1260.
[6]
Lentz SR, Sadler JE. Homocysteine inhibits von will brand factor processing and secretion by preventing transport from the endoplasmic reticulum[J]. Blood,1993,81:683-689
[7]
He K, Merchant A, Rimm EB, et al.Folate, vitamin B6 and Bl2 intakes in relation to risk of stroke among men[ J]. Stroke,2004, 35(1): 169-174.
[8]
Toole JF, Malinow R, Chambless L, et al. Lowering homocystein in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction and death The vitamin intervention for stroke prevention randomized controlled trial[J]. JAMA, 2004, 291(5): 565-575.
